Expansion of Biologics CDMO & Manufacturing Capacity Offerings at Paras Biopharmaceuticals Finland Oy
It is pleased to announce that from Q3-2022, company will be in a position to offer an expanded biologics CDMO capacity to European, USA & Canadian groups. OULU, FINLAND, March 29, 2022 /EINPresswire.com/ — Increased capacity offering comes in the form of expanded production timeslots becoming available due to a successful earlier-than-expected conclusion of a […]
